NIH deltanoids meeting on Vitamin D and cancer: Conclusion and strategic options

Journal of Steroid Biochemistry and Molecular Biology

Volumn 97, Issue 1-2, 2005, Pages 3-5

  Bouillon, Roger ^a   Moody, Terry ^c   Sporn, Michael ^d   Barrett, J Carl ^c   Norman, Anthony W ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

1, ,25 (OH)2D3; Cancer; Deltanoids; Vitamin D; Vitamin D analogs

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CALCITRIOL; DELTANOID; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR MODULATOR;

ACCURACY; APOPTOSIS; BREAST CANCER; CANCER; CANCER CONTROL; CANCER GROWTH; CANCER PREVENTION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CANCER; CONFERENCE PAPER; DRUG EFFECT; DRUG POTENTIATION; FINANCIAL MANAGEMENT; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL PROFESSION; NUTRITION; PREVALENCE; PROSTATE CANCER; VALIDATION PROCESS; VITAMIN D DEFICIENCY;

CONGRESSES; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 27544494264     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.06.016     Document Type: Conference Paper

References (0)